| PET/CT in the Management of Patients With Early Stage Endometrial Cancer (NCT03570866) | Università degli Studi dell'Insubria | 2022-05-01 |
| Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment (NCT06169449) | Peking University People's Hospital | 2022-04-01 |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma (NCT05036681) | M.D. Anderson Cancer Center | 2021-09-30 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. (NCT04205864) | Kocaeli University | 2019-12-20 |
| Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma (NCT03896113) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-11-13 |
| Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study (NCT04014530) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-08-01 |
| Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model (NCT04212910) | IRCCS San Raffaele | 2019-07-23 |
| Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer (NCT03951415) | Leiden University Medical Center | 2019-07-08 |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients (NCT05246462) | Akdeniz University | 2019-03-25 |
| Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery (NCT06187558) | University of Cagliari | 2019-03-01 |
| Relationship of Endometrial Cancer and Serum Soluble L1CAM Level (NCT04603599) | Kocaeli University | 2019-01-01 |
| Multimedia Aid Gynecologic Counseling and Consent (NCT03899441) | UNC Lineberger Comprehensive Cancer Center | 2018-10-01 |
| Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer (NCT04175067) | Muğla Sıtkı Koçman University | 2018-08-01 |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (NCT02997553) | Institut de Cancérologie de Lorraine | 2017-11-29 |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. (NCT03245736) | Seagen Inc. | 2017-08-23 |
| Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors (NCT03095664) | Brazilian National Cancer Institute | 2016-11-01 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02552121) | Seagen Inc. | 2015-11-30 |
| Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. (NCT02221076) | Mauna Kea Technologies | 2014-07-01 |
| Predictive Clinical and Biological Parameters in Gynecological Cancer (NCT01977274) | Institut Paoli-Calmettes | 2013-12-01 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623) | Seagen Inc. | 2013-11-30 |
| ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers (NCT01185626) | Lonneke van de Poll-Franse | 2011-04-01 |
| Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy (NCT01466777) | Tampere University Hospital | 2010-11-01 |
| Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients (NCT01068483) | Novartis Pharmaceuticals | 2008-11-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |